软骨细胞
纤维软骨
软骨
自体软骨细胞移植
细胞生物学
骨关节炎
化学
再生(生物学)
细胞外基质
组织工程
硫氧化物9
软骨发生
细胞生长
解剖
病理
生物
医学
生物医学工程
关节软骨
基因表达
生物化学
替代医学
基因
作者
Piera Smeriglio,Lakshmi Dhulipala,Janice H. Lai,Stuart B. Goodman,Jason L. Dragoo,Robert L. Smith,William J. Maloney,Fan Yang,Nidhi Bhutani
出处
期刊:Tissue Engineering Part A
[Mary Ann Liebert]
日期:2015-02-01
卷期号:21 (3-4): 840-849
被引量:48
标识
DOI:10.1089/ten.tea.2014.0375
摘要
Regeneration of human cartilage is inherently inefficient. Current cell-based approaches for cartilage repair, including autologous chondrocytes, are limited by the paucity of cells, associated donor site morbidity, and generation of functionally inferior fibrocartilage rather than articular cartilage. Upon investigating the role of collagen VI (Col VI), a major component of the chondrocyte pericellular matrix (PCM), we observe that soluble Col VI stimulates chondrocyte proliferation. Interestingly, both adult and osteoarthritis chondrocytes respond to soluble Col VI in a similar manner. The proliferative effect is, however, strictly due to the soluble Col VI as no proliferation is observed upon exposure of chondrocytes to immobilized Col VI. Upon short Col VI treatment in 2D monolayer culture, chondrocytes maintain high expression of characteristic chondrocyte markers like Col2a1, agc, and Sox9 whereas the expression of the fibrocartilage marker Collagen I (Col I) and of the hypertrophy marker Collagen X (Col X) is minimal. Additionally, Col VI-expanded chondrocytes show a similar potential to untreated chondrocytes in engineering cartilage in 3D biomimetic hydrogel constructs. Our study has, therefore, identified soluble Col VI as a biologic that can be useful for the expansion and utilization of scarce sources of chondrocytes, potentially for autologous chondrocyte implantation. Additionally, our results underscore the importance of further investigating the changes in chondrocyte PCM with age and disease and the subsequent effects on chondrocyte growth and function.
科研通智能强力驱动
Strongly Powered by AbleSci AI